<DOC>
	<DOCNO>NCT00000401</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) autoimmune disease characterize swell inflammation joint . In RA , immune system attack person 's cell inside joint , eventually lead joint damage disability . This study determine oral bovine type II collagen ( bovine CII ) lead decrease joint inflammation RA patient .</brief_summary>
	<brief_title>Oral Collagen Rheumatoid Arthritis</brief_title>
	<detailed_description>RA inflammatory disease cause pain , swell , stiffness , loss function joint . The study evaluate effect use oral bovine CII RA patient assess level inflammation marker interferon gamma ( IFN-gamma ) , interleukin-10 ( IL-10 ) , transform growth factor beta ( TGF-beta ) . This study multicenter clinical trial conduct University Tennessee , Memphis ( lead center ) West Tennessee Medical Specialty Clinic ( collaborate site ) . Patients enrol allow continue constant dose disease-modifying anti-rheumatic drug ( DMARDs ) prednisone less equal 7.5 mg/day . Patients randomly assign one two group . The low dose group receive 30 mcg daily 10 week , 50 mcg daily 10 week , follow 70 mcg daily 10 week ; high dose group receive 90 mcg daily 10 week , 100 mcg daily 10 week , follow 130 mcg daily 10 week . Blood collect screening Weeks 10 , 20 , 30 . Blood analyze indicator inflammation . Note : trial longer conduct intervention trial . Accrual discontinue , although patient previously enrol still follow .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Note : accrual trial discontinue , patient previously enrol still follow . Clinically stable RA unlikely require adjustment dos DMARDs , NSAIDs , prednisone , antiTNFα therapy treatment phase study Meets American College Rheumatology ( ACR ) 1988 revise criterion RA Onset disease age 16 old Onset disease least 3 month prior enrollment PBMC IFNγ α1 ( II ) /PBS stimulation index great equal 1.5 6 month prior baseline visit Agree discontinue herbal remedy describe protocol Agree use acceptable form contraception Participation another clinical research study involve evaluation another investigational drug within 90 day prior study entry Currently take great 7.5 mg prednisone daily Intraarticular corticosteroid injection within 30 day prior study entry Concurrent serious medical condition , opinion investigator , make patient inappropriate study Pregnancy Beef allergy Use fish oil within 4 week study entry Previous use auranofin cyclophosphamide ( DMARDs allow ) Previous autologous heterologous stem cell transplantation Active malignancy past treatment consist antineoplastic drug total lymphoid irradiation Intolerance citrus juice colorless carbonate beverage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>NSAIDs</keyword>
	<keyword>Oral Tolerance</keyword>
	<keyword>Drug Interaction</keyword>
	<keyword>Oral Administration</keyword>
	<keyword>Interleukin 10</keyword>
	<keyword>Collagen</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Human Therapy Evaluation</keyword>
	<keyword>DMARDs</keyword>
	<keyword>RA</keyword>
	<keyword>IL-10</keyword>
</DOC>